AGAP7P

Across TCGA pan-cancer cohorts, AGAP7P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of AGAP7P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where AGAP7P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types AGAP7P is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

KIRC, LIHC, and LUSC are the cancer types where AGAP7P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in AGAP7P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+0.104	.038	4	view →
LIHC	Female	II,III,IV	+0.121	.003	3	view →
LUSC	Male	All	+0.330	.016	2	view →
ESCA	All	II,III,IV	+0.229	.030	2	view →
COAD	Female	III,IV	−0.110	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

AGAP7P–KIRC

Open the KIRC breakdown →